Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| IDEAYA Biosciences, Inc.(IDYA) | 1,700,000 | 2,100,000 | +400,000 | $59.69M | $66.53M | 7.45% | +$6.84M |
| Structure Therapeutics IncADS | 1,100,000 | 1,250,000 | +150,000 | $43.20M | $54.86M | 6.15% | +$11.67M |
| Revolution Medicines, Inc.(RVMD) | 1,200,000 | 1,200,000 | 0 | $46.57M | $54.42M | 6.10% | +$7.85M |
| Disc Medicine, Inc.(IRON) | 925,000 | 935,000 | +10,000 | $41.69M | $45.95M | 5.15% | +$4.26M |
| Janux Therapeutics, Inc.(JANX) | 750,000 | 1,000,000 | +250,000 | $31.42M | $45.43M | 5.09% | +$14.01M |
| Olema Pharmaceuticals, Inc.(OLMA) | 3,208,875 | 3,208,875 | 0 | $34.72M | $38.31M | 4.29% | +$3.59M |
| Vaxcyte, Inc.(PCVX) | 0 | 300,000 | +300,000 | $0 | $34.28M | 3.84% | +$34.28M |
| Immunovant, Inc.(IMVT) | 575,000 | 1,100,000 | +525,000 | $15.18M | $31.36M | 3.51% | +$16.18M |
| Celldex Therapeutics, Inc.(CLDX) | 0 | 900,000 | +900,000 | $0 | $30.59M | 3.43% | +$30.59M |
| Ocular Therapeutix, Inc.(OCUL) | 5,150,000 | 3,500,000 | -1,650,000 | $35.23M | $30.45M | 3.41% | -$4.78M |
| Ionis Pharmaceuticals, Inc.(IONS) | 300,000 | 750,000 | +450,000 | $14.30M | $30.05M | 3.37% | +$15.75M |
| Erasca, Inc.(ERAS) | 5,900,000 | 10,900,000 | +5,000,000 | $13.92M | $29.76M | 3.33% | +$15.83M |
| Merus N V | 850,000 | 575,000 | -275,000 | $50.29M | $28.73M | 3.22% | -$21.57M |
| Lakefront Biotherapeutics NVADR(LKFT) | 0 | 800,000 | +800,000 | $0 | $23.03M | 2.58% | +$23.03M |
| Akero Therapeutics Inc | 800,000 | 800,000 | 0 | $18.77M | $22.95M | 2.57% | +$4.18M |
| Design Therapeutics, Inc.(DSGN) | 5,032,501 | 4,217,627 | -814,874 | $16.86M | $22.69M | 2.54% | +$5.83M |
| Vera Therapeutics, Inc.CL A(VERA) | 950,000 | 500,000 | -450,000 | $34.37M | $22.10M | 2.48% | -$12.27M |
| Cogent Biosciences, Inc.(COGT) | 0 | 2,000,000 | +2,000,000 | $0 | $21.60M | 2.42% | +$21.60M |
| Cytokinetics, Incorporated(CYTK) | 0 | 400,000 | +400,000 | $0 | $21.12M | 2.37% | +$21.12M |
| Bicara Therapeutics Inc | 0 | 800,000 | +800,000 | $0 | $20.38M | 2.28% | +$20.38M |
| Sarepta Therapeutics, Inc.(SRPT) | 150,000 | 150,000 | 0 | $23.70M | $18.73M | 2.10% | -$4.97M |
| Annexon, Inc.(ANNX) | 3,300,000 | 2,600,000 | -700,000 | $16.17M | $15.39M | 1.72% | -$778.0K |
| Travere Therapeutics, Inc.(TVTX) | 0 | 1,100,000 | +1,100,000 | $0 | $15.39M | 1.72% | +$15.39M |
| Enliven Therapeutics Inc | 595,000 | 495,000 | -100,000 | $13.91M | $12.64M | 1.42% | -$1.26M |
| Beam Therapeutics Inc.(BEAM) | 0 | 500,000 | +500,000 | $0 | $12.25M | 1.37% | +$12.25M |
| Edgewise Therapeutics, Inc.(EWTX) | 0 | 450,000 | +450,000 | $0 | $12.01M | 1.35% | +$12.01M |
| Bicycle Therapeutics PlcADS | 0 | 500,000 | +500,000 | $0 | $11.31M | 1.27% | +$11.31M |
| Y-Mabs Therapeutics Inc | 0 | 800,000 | +800,000 | $0 | $10.52M | 1.18% | +$10.52M |
| Arvinas, Inc.(ARVN) | 0 | 400,000 | +400,000 | $0 | $9.85M | 1.10% | +$9.85M |
| Trevi Therapeutics, Inc.(TRVI) | 2,800,000 | 2,750,000 | -50,000 | $8.34M | $9.19M | 1.03% | +$841.0K |
| Nuvalent Inc | 195,000 | 75,000 | -120,000 | $14.79M | $7.67M | 0.86% | -$7.12M |
| COMPASS Pathways plcADS(CMPS) | 1,159,030 | 1,159,030 | 0 | $7.00M | $7.30M | 0.82% | +$301.3K |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 257,330 | +257,330 | $0 | $6.31M | 0.71% | +$6.31M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 350,000 | 325,000 | -25,000 | $7.54M | $6.00M | 0.67% | -$1.53M |
| Spyre Therapeutics, Inc.(SYRE) | 575,000 | 200,000 | -375,000 | $13.52M | $5.88M | 0.66% | -$7.64M |
| Dyne Therapeutics, Inc.(DYN) | 265,000 | 160,000 | -105,000 | $9.35M | $5.75M | 0.64% | -$3.60M |
| Astria Therapeutics Inc | 500,000 | 500,000 | 0 | $4.55M | $5.50M | 0.62% | +$955.0K |
| Cybin D/B/A Helus Pharma(HELP) | 0 | 600,000 | +600,000 | $0 | $5.33M | 0.60% | +$5.33M |
| Engene Holdings Inc COM | 1,200,000 | 800,000 | -400,000 | $11.32M | $5.28M | 0.59% | -$6.04M |
| Avalo Therapeutics, Inc.(AVTX) | 539,079 | 539,079 | 0 | $6.72M | $5.12M | 0.57% | -$1.60M |
| Lineage Cell Therapeutics, Inc.(LCTX) | 4,700,000 | 5,000,000 | +300,000 | $4.69M | $4.53M | 0.51% | -$160.8K |
| Rapport Therapeutics, Inc.(RAPP) | 208,910 | 208,910 | 0 | $4.37M | $4.06M | 0.46% | -$308.8K |
| Silence Therapeutics plcADS(SLN) | 1,476,061 | 200,000 | -1,276,061 | $28.05M | $3.64M | 0.41% | -$24.41M |
| Atyr Pharma Inc | 3,000,000 | 2,000,000 | -1,000,000 | $4.68M | $3.52M | 0.39% | -$1.16M |
| Nextcure Inc | 2,500,000 | 2,500,000 | 0 | $3.98M | $3.42M | 0.38% | -$550.0K |
| Adverum Biotechnologies Inc | 416,666 | 416,666 | 0 | $2.86M | $2.92M | 0.33% | +$66.7K |
| Artiva Biotherapeutics, Inc.(ARTV) | 0 | 145,089 | +145,089 | $0 | $2.13M | 0.24% | +$2.13M |
| Unicycive Therapeutics Inc | 3,469,927 | 5,078,927 | +1,609,000 | $1.74M | $2.07M | 0.23% | +$332.9K |
| Allakos Inc | 2,900,000 | 2,900,000 | 0 | $2.90M | $1.89M | 0.21% | -$1.01M |
| Neumora Therapeutics, Inc.(NMRA) | 300,000 | 100,000 | -200,000 | $2.95M | $1.32M | 0.15% | -$1.63M |
| Io Biotech Inc | 493,827 | 493,827 | 0 | $577.8K | $518.5K | 0.06% | -$59.3K |
| Skye Bioscience, Inc.(SKYE) | 1,301,518 | 100,000 | -1,201,518 | $10.43M | $391.0K | 0.04% | -$10.03M |
| Boundless Bio, Inc.(BOLD) | 117,806 | 58,903 | -58,903 | $433.1K | $204.4K | 0.02% | -$228.7K |
| Apellis Pharmaceuticals Inc COM | 400,000 | 0 | -400,000 | $15.34M | $0 | — | -$15.34M |
| Applied Therapeutics Inc | 600,000 | 0 | -600,000 | $2.66M | $0 | — | -$2.66M |
| argenx SEADR(ARGX) | 135,000 | 0 | -135,000 | $58.06M | $0 | — | -$58.06M |
| Biohaven Ltd.(BHVN) | 250,000 | 0 | -250,000 | $8.68M | $0 | — | -$8.68M |
| Cartesian Therapeutics, Inc.(RNAC) | 90,000 | 0 | -90,000 | $2.43M | $0 | — | -$2.43M |
| Cybin D/B/A Helus Pharma(HELP) | 40,000,000 | 0 | -40,000,000 | $10.84M | $0 | — | -$10.84M |
| Elevation Oncology Inc | 3,850,000 | 0 | -3,850,000 | $10.39M | $0 | — | -$10.39M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 750,000 | 0 | -750,000 | $32.98M | $0 | — | -$32.98M |
| Nuvation Bio Inc.W EXP 07 07 202(NUVB) | 66,666 | 0 | -66,666 | $10.7K | $0 | — | -$10.7K |
| Relay Therapeutics, Inc.(RLAY) | 1,300,000 | 0 | -1,300,000 | $8.48M | $0 | — | -$8.48M |
| Stoke Therapeutics, Inc.(STOK) | 1,050,000 | 0 | -1,050,000 | $14.19M | $0 | — | -$14.19M |
| Xencor, Inc.(XNCR) | 1,500,000 | 0 | -1,500,000 | $28.39M | $0 | — | -$28.39M |
| Xenon Pharmaceuticals Inc.(XENE) | 375,000 | 0 | -375,000 | $14.62M | $0 | — | -$14.62M |